Officials at a life sciences startup based on a Purdue University innovation say their technology could help pharmaceutical companies find more effective drug candidates and improve the results of personalized cancer care.
Analytical Chemistry
Nov 5, 2014
0
0
Potentially valuable drugs slowed down by sticky molecules may get another shot at success. Joint research by the National Institute of Standards and Technology (NIST), Genentech, the University of Delaware and Institut Laue-Langevin ...
Biochemistry
Apr 23, 2014
0
0
By 2018, it is estimated that the global pharmaceutical market will be worth more than $1.3 trillion USD. To corner their share of profits, established drug companies have to fight fierce competition from generic products, ...
Social Sciences
Feb 4, 2014
0
0
Becton, Dickinson and Co.'s announcement that it was about to roll out a new, easy-to-use, disposable pen injector called Vystra hardly caused a stir last October. Although an executive for the Franklin Lakes, N.J.-based ...
Other
Jun 20, 2013
0
0
Muthu Alagappan arrived at Stanford University with his heart set on attending medical school, and he still hopes to become a doctor someday.
Mathematics
Jun 20, 2013
0
0
Scientists working at the Institut Laue-Langevin have shown that the charge of gold nanoparticles, identified by major pharmaceutical companies as a drug delivery agent of the future for the treatment of cancer, affects how ...
Bio & Medicine
Jun 7, 2013
0
1
Shaken, not stirred, is the essence of new research that's showing promise in creating the chemical reactions necessary for industries such as pharmaceutical companies, but eliminating the resulting waste from traditional ...
Materials Science
Apr 8, 2013
0
0
(Phys.org)—Sean Hemp of Raleigh, N.C., a Ph.D. student in chemistry in the College of Science, is helping to invent new therapies that target genetic disease and cancer.
Bio & Medicine
Jan 28, 2013
0
0
Side effects are a major reason that drugs are taken off the market and a major reason why patients stop taking their medications, but scientists are now reporting the development of a new way to predict those adverse reactions ...
Other
Jan 2, 2013
1
0
A new stem cell-derived system for screening experimental drugs for cardiotoxicity could identify dangerous side effects early in the development process, thereby potentially saving time, lives and money, according to Evan ...
Cell & Microbiology
Dec 17, 2012
0
0
